We are live on ! Find out more
CC

Corton Capital Portfolio holdings

AUM $40.7M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
+19.06%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$31.4M
Cap. Flow
-$50.7M
Cap. Flow %
-29.09%
Top 10 Hldgs %
48.99%
Holding
691
New
222
Increased
56
Reduced
93
Closed
319

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$614K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$592K
3
AMAT icon
Applied Materials
AMAT
+$582K
4
SBGI icon
Sinclair Inc
SBGI
+$529K
5
PRAA icon
PRA Group
PRAA
+$525K

Top Sells

Rank Stock Value
1
IGMS
IGM Biosciences
IGMS
+$1.1M
2
ROOT icon
Root
ROOT
+$981K
3
CDNA icon
CareDx
CDNA
+$929K
4
TRDA icon
Entrada Therapeutics
TRDA
+$924K
5
SO icon
Southern Company
SO
+$883K

Sector Composition

Rank Sector Weight
1 Technology 55.81%
2 Healthcare 9.35%
3 Financials 7.03%
4 Industrials 6.34%
5 Consumer Discretionary 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
351
Kura Oncology
KURA
$800M
$98.8K 0.06%
+11,344
New +$163K
NABL icon
352
N-able
NABL
$882M
$93.5K 0.05%
+10,014
New +$112K
LXEO icon
353
Lexeo Therapeutics
LXEO
$324M
$90.6K 0.05%
+13,771
New +$108K
GTN icon
354
Gray Television
GTN
$415M
$89.5K 0.05%
28,420
+16,589
+140% +$77.4K
CDE icon
355
Coeur Mining
CDE
$15.4B
$87.9K 0.05%
+15,368
New +$99.6K
XRN
356
Chiron Real Estate Inc
XRN
$514M
$84.8K 0.05%
+2,197
New +$97.2K
VMD icon
357
Viemed Healthcare
VMD
$447M
$81.9K 0.05%
+10,208
New +$88.6K
TNGX icon
358
Tango Therapeutics
TNGX
$4.43B
$75.4K 0.04%
+24,408
New +$113K
ACRV icon
359
Acrivon Therapeutics
ACRV
$64.2M
$73.2K 0.04%
+12,159
New +$88.4K
ANNX icon
360
Annexon
ANNX
$835M
$70.5K 0.04%
13,741
-3,700
-21% -$22.8K
PEPG icon
361
PepGen
PEPG
$122M
$67.6K 0.04%
+17,833
New +$111K
CATX icon
362
Perspective Therapeutics
CATX
$332M
$61.2K 0.04%
+19,180
New +$157K
SGHT icon
363
Sight Sciences
SGHT
$286M
$57.6K 0.03%
15,832
+3,445
+28% +$15.7K
REAX icon
364
Real Brokerage
REAX
$349M
$51.3K 0.03%
+11,147
New +$58.5K
KYTX icon
365
Kyverna Therapeutics
KYTX
$444M
$45.3K 0.03%
+12,099
New +$58K
NVRO
366
DELISTED
NEVRO CORP.
NVRO
$42.7K 0.02%
+11,487
New +$53K
AGL icon
367
Agilon Health
AGL
$1.53B
$42.4K 0.02%
893
-1,980
-69% -$120K
SLDB icon
368
Solid Biosciences
SLDB
$794M
$40.6K 0.02%
+10,152
New +$55.8K
AGEN
369
Agenus
AGEN
$312M
$36K 0.02%
+13,141
New +$48.6K
ZNTL icon
370
Zentalis Pharmaceuticals
ZNTL
$337M
$31.5K 0.02%
+10,412
New +$34.1K
LESL icon
371
Leslie's
LESL
$8.9M
$26.5K 0.02%
594
-165
-22% -$8.76K
CHGG icon
372
Chegg
CHGG
$110M
$18.5K 0.01%
+11,467
New +$21.1K
ABNB icon
373
Airbnb
ABNB
$89.9B
– –
-2,698
Closed -$342K
ACEL icon
374
Accel Entertainment
ACEL
$978M
– –
-17,380
Closed -$202K
ACIW icon
375
ACI Worldwide
ACIW
$5.83B
– –
-5,598
Closed -$285K
13 14
15
16 17

Similar funds

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
AM
Arkhouse Management New York $36.7M AUM
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
OC
ORIX Corp Tokyo, Japan $36.6M AUM 25.1% 1-Year Est. Return
HCM
HGI Capital Management New York $36.4M AUM 4.49% 1-Year Est. Return
PI
Pelion Inc Salt Lake City, Utah $36.3M AUM 3.33% 1-Year Est. Return

Corton Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Corton Capital held 691 positions worth $174M, down 15% from $206M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Corton Capital withdrew a net $50.7M in Q4 2024, closing 319 positions and reducing 93 holdings. Its most notable exit was IGM Biosciences, an estimated $1.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Corton Capital opened a new position in Progressive worth $585K.

  • Corton Capital's largest Q4 2024 buy was Progressive: 2,441 shares worth $585K.
  • Corton Capital added most to United Natural Foods in Q4 2024, an estimated $439K increase.
  • Corton Capital's biggest Q4 2024 reduction was Root, cutting an estimated $981K.
  • Corton Capital fully exited IGM Biosciences in Q4 2024, selling an estimated $1.1M.
  • Corton Capital's ten largest holdings make up 49% of its $174M portfolio in Q4 2024.
  • Corton Capital opened 222 new positions and closed 319 in Q4 2024.
  • Corton Capital's portfolio value fell 15% quarter-over-quarter to $174M.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.